Dear Colleagues,

On behalf of the American Association for Cancer Research (AACR), we have the great pleasure to invite you to attend the 4th AACR New Horizons in Cancer Research Conference: Research Propelling Cancer Prevention and Cures, which will be held from November 6-9, 2017, in Shanghai, China.

This year, we are honored that Fudan University will be a partner for the conference. An outstanding roster of international speakers and local experts will highlight some of the very latest discoveries in cancer science and medicine presented at the AACR Annual Meeting 2017 in the U.S. Presentations will span the entire spectrum of cancer research, and this meeting will aid basic researchers, physicians, and clinician-scientists in obtaining, synthesizing, and integrating the most cutting-edge research.

The conference will begin with two Keynote Addresses during the opening plenary session, followed by eight plenary sessions on topics covering the entire cancer research spectrum, including: Tumor Evolution, Cancer Genomics, Epigenetics, Metabolism, Tumor Microenvironment and Inflammation, Immunology, Prevention, and Precision Medicine. This interactive four-day program will also feature educational sessions on Genome Editing and Clinical Trial Design and two poster sessions developed from submitted abstracts.

We invite you to join us at the Shanghai Marriott Parkview Hotel for the 2017 AACR New Horizons in Cancer Research Conference, a meeting that has quickly become a must-attend event in the Asia-Pacific region. We expect to welcome a large number of attendees from this region and from around the world to this landmark conference in Shanghai, and we are thrilled to provide this opportunity for scientific interaction.

We look forward to receiving your abstract submissions and seeing you in Shanghai in November. We are confident that you will find this to be an engaging and insightful meeting, and we hope that you will take full advantage of the opportunity to network with colleagues and forge collaborations that will bring us all closer to our unified mission to prevent and cure cancer.

Sincerely,

Nancy E. Davidson, MD
Past President, AACR (2016-2017)
Conference Cochair
Fred Hutchinson Cancer Center, Seattle, WA, USA

Kornelia Polyak, MD, PhD
Conference Cochair
Dana Farber Cancer Institute, Boston, MA, USA

Chi Van Dang, MD, PhD
Conference Cochair
Abramson Cancer Center of University of Pennsylvania, Philadelphia, PA, USA

Hongyang Wang, MD, PhD
Conference Cochair
National Center for Liver Cancer, Shanghai, P.R. China

http://nhicr.aacr.asia/